(Q34539558)

2 August 2017

1 reference

title

High-dose chemotherapy and autologous bone marrow transplantation in diffuse intermediate- and high-grade non-Hodgkin lymphoma (English)

1 reference

2 August 2017

1 reference

Thierry Philip

1

1 reference

2 August 2017

Pierre Biron

series ordinal

2

1 reference

2 August 2017

publication date

1 February 2002

1 reference

Critical Reviews in Oncology Hematology

2 August 2017

published in

1 reference

2 August 2017

volume

41

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

213-223

1 reference

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

The role of massive therapy with autologous bone marrow transplantation in Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

Role of high-dose chemotherapy and autologous bone marrow transplantation in the treatment of lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

All roads lead to depression: clinically homogeneous, etiologically heterogeneous

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

Consensus conference on intensive chemotherapy plus hematopoietic stem cell transplantation in malignancies, Lyon, June 4-6, 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900158-5

7 January 2021

10.1016/S1040-8428(01)00158-5

Identifiers

DOI

1 reference

2 August 2017

1 reference